Cowen And Company, LLC Biocryst Pharmaceuticals Inc Call Options Transaction History

Cowen And Company, LLC

  • $3.91 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 04, 2021
SELL
$7.37 - $13.61 $227,733 - $420,549
-30,900 Closed
0 $0
Q4 2020

Feb 08, 2021
BUY
$3.37 - $8.61 $104,133 - $266,049
30,900 New
30,900 $55,000
Q3 2020

Nov 03, 2020
SELL
$3.43 - $5.53 $77,175 - $124,425
-22,500 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$1.9 - $5.61 $42,750 - $126,225
22,500 New
22,500 $2,000

Others Institutions Holding BCRX

# of Institutions
260
Shares Held
173M
Call Options Held
397K
Put Options Held
444K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email